Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 6/20 | 0.55 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9748326 | 1.00 | AR (0.55) | ARSRD5A2KCNH2 | |
| SCHEMBL5339929 | 0.89 | AR (0.58) | ARSRD5A2KCNH2 | |
| SCHEMBL5247468 | 0.89 | AR (0.58) | ARSRD5A2KCNH2 | |
| SCHEMBL9830070 | 0.88 | SRD5A2 (0.52) | ARSRD5A2KCNH2 | |
| SCHEMBL9830063 | 0.88 | SRD5A2 (0.52) | ARSRD5A2KCNH2 | |
| SCHEMBL5219066 | 0.87 | SRD5A1 (0.61) | ARSRD5A2 | |
| SCHEMBL7083069 | 0.87 | SRD5A1 (0.61) | ARSRD5A2 | |
| SCHEMBL5874196 | 0.86 | AR (0.74) | ARSRD5A2KCNH2 | |
| SCHEMBL5247649 | 0.86 | AR (0.74) | ARSRD5A2KCNH2 | |
| SCHEMBL13403347 | 0.86 | AR (0.74) | ARSRD5A2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5138063-A | Testosterone reductase inhibitors | MERCK & CO., INC. (US) | 1992-08-11 | — | — | US | disclosed |
| EP-0462661-A2 | Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors | MERCK & CO. INC. (US) | 1991-12-27 | — | — | EP | disclosed |
| EP-0462668-A2 | New 17beta-aminobenzoyl-4-aza-5alpha-androst-1-en-3-ones as benign prostatic hypertrophy agents | MERCK & CO. INC. (US) | 1991-12-27 | — | — | EP | disclosed |